Stimcell Energetics (STME) Net Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -88.31% |
| Nov 30, 2025 | 19.22% |
| Aug 31, 2025 | -16.08% |
| May 31, 2025 | 16.14% |
| Feb 28, 2025 | 30.05% |
| Nov 30, 2024 | 16.79% |
| Aug 31, 2024 | -15.75% |
| May 31, 2024 | 12.03% |
| Feb 29, 2024 | -11.97% |
| Nov 30, 2023 | -54.42% |
| Aug 31, 2023 | -57.17% |
| May 31, 2023 | 51.40% |
| Feb 28, 2023 | 33.94% |
| Nov 30, 2022 | 15.33% |
| Aug 31, 2022 | -15.52% |
| May 31, 2022 | -16.09% |
| Feb 28, 2022 | 42.79% |
| Nov 30, 2021 | -18.38% |
| Aug 31, 2021 | 32.30% |
| May 31, 2021 | -18.90% |
| May 31, 2018 | -56.96% |
| Feb 28, 2018 | -68.29% |
| Nov 30, 2017 | -115.46% |
| May 31, 2017 | 62.46% |
| Feb 28, 2017 | -41.54% |
| May 31, 2016 | 26.50% |